Diabetes patients to get access to new weight-loss drug ‘in weeks’

iStock/golibo

By Ellie Ng, PA

A weight loss drug newly approved in a four-dose injection pen format by the Medicines and Healthcare products Regulatory Agency (MHRA) could be supplied to the UK “within weeks”.

Tirzepatide, sold under the brand name Mounjaro, is a diabetes drug that was authorised by the MHRA to help obese and overweight adults with weight management and loss in November last year.